Clinical Trial Update: Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing subcutaneous CD-NP in heart failure patients with left ventricular assist device support was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CD-NP (CD-NP)

Snippet

Sponsor: Mayo Clinic | Conditions: Heart Failure, Left Ventricular Assist Device | Phase 1 | Status: WITHDRAWN